Targazyme Inc - Company & Market Research Reports

Targazyme is a clinical-stage biopharmaceutical company developing and commercializing breakthrough products to improve clinical efficacy outcomes for immunotherapies for cancer and autoimmune diseases, stem cell transplants, gene therapy and regenerative medicine. Targazyme's products are off-the-shelf enzyme/substrate kits that are used to treat cells at the point-of-care, immediately before they are infused in the patient. The company was founded in 2005 and is based in Floresville, Texas with additional offices in San Diego, California; and Basel, Switzerland.

From
From
From
From
From
From
From
From
From
CAR-T Therapies Market, 2018-2030 - Product Thumbnail Image

CAR-T Therapies Market, 2018-2030

  • Report
  • 548 Pages
From
From
From
From
From
  • 17 Results (Page 1 of 1)
Loading Indicator
adroll